Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EOG Resources Inc (EOG) vs Novavax Inc (NVAX) Price & Performance

EOG Resources IncTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

EOG Resources Inc vs Novavax Inc — how do they compare? EOG Resources Inc trades at $142.98 (market cap $75.22B), while Novavax Inc trades at $7.95 (market cap $1.31B). The key difference: EOG Resources Inc is far larger — about 57.4× Novavax Inc's market cap, and EOG Resources Inc pays a 2.85% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

EOGNVAX
Market Cap
$75.22B$1.31B
Sector
EnergyHealth
52-Week High
$149.89$11.19
52-Week Low
$101.78$6.22
Enterprise Value
$78.56B$889.30M
Dividend Yield
2.85%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

EOG Resources Inc

EOG Resources trades at $142.4, up 0.13% today, with a bullish technical signal and strong fundamentals. The stock shows robust profitability with a 25.81% net income margin and a low P/E of 11.16. Recent Q2 2026 earnings of $5.07 per share beat estimates, driven by higher oil prices and production. Analyst consensus is a Buy with a $157.88 price target, and institutional interest remains positive.

The outlook for EOG is favorable, supported by consistent earnings beats, shareholder returns via dividends, and a disciplined growth strategy. Key risks include oil price volatility and capital expenditure outflows. The stock presents a value opportunity with upside potential, but investors should monitor energy market trends and execution on international projects.

Novavax Inc

Novavax (NVAX) trades at $7.97, up 1.01% with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported strong Q2 2026 results, beating revenue and earnings estimates while raising full-year guidance. Despite negative profitability metrics, valuation ratios appear attractive with P/E of 3.14 and EV/EBITDA of 1.72. Recent news highlights progress with Sanofi partnership and cost reduction initiatives.

The outlook remains challenged by negative cash flows and accumulated deficits, but analyst sentiment is positive with 74% buy ratings. Key risks include ongoing operational losses and vaccine demand volatility, while potential upside exists from partnership milestones and adjuvant platform expansion. The stock presents a high-risk opportunity with significant analyst support despite fundamental weaknesses.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About EOG Resources Inc

EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.

Read more on EOG

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX